Skip to content

ICH

ICH Q9(R1) 8

REFERENCES

Section text

1. ICH Q8 Pharmaceutical Development.

2. ICH Q10 Pharmaceutical Quality System.

3. ICH Q11 Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities).

4. ICH Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.

5. ISO/IEC Guide 73:2009 - Risk Management - Vocabulary - Guidelines for use in Standards.

6. ISO/IEC Guide 51:2014 - Safety Aspects - Guideline for their inclusion in standards.

7. IEC 61025 - Fault Tree Analysis (FTA).

8. IEC 60812:2018 Failure modes and effects analysis (FMEA and FMECA).

9. IEC 61882:2016 - Hazard and operability studies (HAZOP studies) – Application guide.

10. ISO 14971:2019 – Medical devices - Application of risk management to medical devices.

11. ISO 7870-1:2019 - Control Charts, General guidelines.

12. ISO 7870-4:2021- Cumulative Sum Charts.

13. ISO 7870-3:2020 - Acceptance Control Charts.

14. ISO 7870-2:2013 - Shewhart Control Charts.

15. WHO Technical Report Series No 908, 2003, Annex 7 Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals.

16. What is Total Quality Control?; The Japanese Way, Kaoru Ishikawa (Translated by David J. Liu), 1985, ISBN 0139524339.

17. Failure Mode and Effect Analysis, FMEA from Theory to Execution, 2nd Edition 2003, D. H. Stamatis, ISBN 0873895983.

18. Process Mapping by the American Productivity & Quality Center, 2002, ISBN 1928593739.

19. Parenteral Drug Association. Technical Report No. 54 Implementation of quality risk management for pharmaceutical and biotechnology manufacturing operations. 2012.

20. Parenteral Drug Association. Points to consider for aging facilities. 2017.

21. Parenteral Drug Association. Technical Report No. 68. Risk-based approach for prevention and management of drug shortages. 2014.

22. International Society for Pharmaceutical Engineering. Report on the ISPE Drug shortages survey. 2013.

23. International Society for Pharmaceutical Engineering. Drug shortages prevention plan. 2014.

24. Tabersky D, Woelfle M, Ruess J, Brem S, Brombacher S. Recent regulatory trends in pharmaceutical manufacturing and their impact on the industry. CHIMIA, 2018;72(3):146-150.

25. O’Donnell K, Tobin D, Butler S, Haddad G, Kelleher D. Understanding the concept of formality in quality risk management. J. Valid. Technol, 2020 Jun; 26(3).

Source: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.